Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Hypersensitivity Publisher



Momtazmanesh S1, 2 ; Rezaei N1, 2, 3
Authors

Source: Encyclopedia of Infection and Immunity Published:2022


Abstract

Hypersensitivity as an immunological dysfunction is defined as exaggerated or inappropriate response of the immune system, which is mostly targeted at innocuous antigens with consequent tissue damage. Hypersensitivity can be classified into four types; namely, type I (Immediate), type II (antibody-mediated), type III (immune complex-mediated), and type IV (cell-mediated or delayed-type) hypersensitivity. Type I hypersensitivity or allergy, the most common immune disorder, is mainly mediated by immunoglobulin (Ig)E and mast cells. It can cause anaphylaxis, food allergy, and asthma. Type II hypersensitivity can lead to tissue damage by three main mechanisms: (1) direct cellular destruction (e.g., autoimmune hemolytic anemia and immune thrombocytopenia), (2) inflammation (e.g., Goodpasture's syndrome and acute rheumatic fever), and (3) disrupting cellular function (e.g., myasthenia gravis and Graves’ disease). Type III hypersensitivity is caused by excess production of immune complexes or impaired clearance of them and includes serum sickness, systemic lupus erythematosus, and post-streptococcal glomerulonephritis. Type IV hypersensitivity is mediated by T cells and macrophages, causing diseases like multiple sclerosis and rheumatoid arthritis. In this chapter, we explained the underlying mechanism of action of each type of hypersensitivity and provided definition, epidemiological and clinical features, diagnostic methods, and treatments for disorders caused by each mechanism. © 2022 Elsevier Inc. All rights reserved.
Other Related Docs
7. Anti-Ige Monoclonal Antibodies As Potential Treatment in Covid-19, Immunopharmacology and Immunotoxicology (2021)
9. Efficacy and Safety of Omalizumab in Paediatric Age: An Update of Literature Data, Journal of Biological Regulators and Homeostatic Agents (2016)
17. Autoimmunity in Patients With Selective Iga Deficiency, Journal of Investigational Allergology and Clinical Immunology (2015)
20. Crosstalk Between Chitosan and Cell Signaling Pathways, Cellular and Molecular Life Sciences (2019)